Clinical Trials

Clinical trials are research studies conducted to evaluate the safety and efficacy of new medical interventions, such as drugs or therapies, on human participants.

Why it’s in the news: Clinical trials are in the news due to new government initiatives to accelerate them with AI, significant funding for AI-driven drug trials, and growing scrutiny over their conduct and participant shortages.

Latest on Clinical Trials

• STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
• Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
• Rising US scrutiny on clinical trials could threaten China’s biotech advantage: analysts
• Clinical trials for Alzheimer’s treatment face global shortage of participants
• STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
• STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed
• Anew Labs raised $290 million, but no one in that boardroom can explain the black box decisions that will now shape clinical trials. Generative models hallucinate molecules and pathways with zero liability.
• Why the future of clinical trials depends on understanding patients, not just drugs

Connections

6 entities linked to Clinical Trials across the news graph.